Wilson_1. LU Abstract for BSCGT_HUMAN GENE THERAPY 2017_word accepted.pdf (98.95 kB)
Download file

Quality approaches to allow multi-site equivalence in pluripotent stem cell based product manufacturing [Abstract]

Download (98.95 kB)
conference contribution
posted on 13.08.2018, 13:48 by Maryam Shariatzadeh, Sammy WilsonSammy Wilson, Amit Chandra, Sujith Sebastian, Mark McCall, Rob ThomasRob Thomas, Nick Medcalf, Zoe Hewitt, David Williams
Quality approaches to allow multi-site equivalence in pluripotent stem cell based product manufacturing [Abstract]

History

School

  • Mechanical, Electrical and Manufacturing Engineering

Published in

Annual Conference of the British-Society-for-Gene-and-Cell-Therapy / Joint UK-Regenerative-Medicine-Platform Meeting HUMAN GENE THERAPY

Volume

28

Issue

8

Pages

A21 - A21

Citation

SHARIATZADEH, M. ... et al., 2017. Quality approaches to allow multi-site equivalence in pluripotent stem cell based product manufacturing. Human Gene Therapy, 28(8), pp. A21.

Publisher

Mary Ann Liebert Publications

Version

AM (Accepted Manuscript)

Publisher statement

This work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/

Acceptance date

19/04/2017

Publication date

2017

Notes

This paper was presented at the annual conference of the British-Society-for-Gene-and-Cell-Therapy / Joint UK-Regenerative-Medicine-Platform Meeting, Royal Welsh Coll Mus & Drama, Cardiff, WALES, April 19–April 21. Final publication is available from Mary Ann Liebert, Inc., publishers https://doi.org/10.1089/hum.2017.29044.abstracts

ISSN

1043-0342

eISSN

1557-7422

Language

en

Location

Royal Welsh Coll Mus & Drama, Cardiff, WALES

Usage metrics

Keywords

Exports